Access Curated Private Market Opportunities
Award-winning Platform Empowering Innovation, Capital and Ambition, Globally
-
0
+
Investors & Deal Makers
-
0
Unicorns
-
0
Year track record
POWERED BY CapitalHQTM
Utilise our cutting-edge AI-powered platform to access curated Private Opportunities. Discover Startups, Scaleups, Fund Managers, Private Equity, Property, Small Cap Listed and Secondary Market Opportunities
Join an exclusive ecosystem of High-Net-Worth, Professional, Institutional, VC and Family Office Investors. Receive personalised deal flow, streamlined information access and access to investment insights from leading global Fund Managers and Investors
Access Exclusive Private Opportunities
Get access to curated growth companies, property opportunities, alternative funds, investment insights and exclusive investor networking events
- Free Account Set up
- No transaction fees
- Direct Access to CEOs and Managers
- Curated Global Deal Flow
QBiotics Group
The Insides Company
NanoFynd Pty Ltd
Navi Medical Technologies
Elemental IV
SoHi Partners
A Personalised Pipeline of Opportunities
Let our AI/ML provide you with personalised, exclusive and consistent deal flow
QBiotics Group
The Insides Company
NanoFynd Pty Ltd
Navi Medical Technologies
Elemental IV
SoHi Partners
- Overview
- Market Opportunity
- Competitive Advantage
- Highlights and Milestones
- Investment Offering
Streamlined Investor Experience
Access the information you want and need, in a structured, clear format.
Trusted by hundreds of companies worldwide
Our international clientele includes leading emerging growth companies, funds, governments, universities, incubators, accelerators and advisory firms.
Premier Investor Events and Conferences
See exclusive pitches, product demos, and talk with founders
In person or online
Yield & Growth – Investment Conference – SYDNEY 2026
Yield & Growth – Investment Conference – SINGAPORE 2026
As seen in
News and announcements
Our Clients’ Major Breakthrough and Milestones
Reinventing the Condom: How an Australian Deep-Tech Startup Plans to Disrupt a $12 Billion Market
For more than half a century, the global condom industry has remained fundamentally unchanged, constrained by standard materials like latex and solid synthetic polymers. Despite widespread consumer demand for better alternatives, product design has treated the device strictly as a mechanical barrier, sacrificing feel for function. Sydney-based Eudaemon Technologies is setting out to upend that […]
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
How to Raise Capital from Wholesale Investors in Australia
Raising capital from wholesale investors is the most efficient path to funding for Australian companies that want to avoid the cost, time, and regulatory burden of producing a full prospectus. Under Section 708 of the Corporations Act 2001, companies can raise capital from investors without a disclosure document, provided specific exemptions are met. This guide […]
See more exiting opportunities on CapitalHQ
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,…
HorizonTwo Capital Partners
HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.
The Insides Company
First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.
DCARB
We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.
Grabba Technologies Pty Ltd
Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.
Backed By Leading Investment Groups and Family Offices
